Solicitud de beca Wylie
Ya está abierto el plazo de solicitud para la Beca Wylie 2025. Las preguntas sobre la beca y la presentación de solicitudes deben enviarse a grants@vascularcures.org . La fecha límite para la presentación de solicitudes es el 1 de abril de 2025.
La beca Wylie 2025 de la Fundación para el Avance de las Curas Vasculares es una subvención de $50,000 con una duración de un año, destinada a apoyar a jóvenes cirujanos-científicos vasculares sobresalientes que se dedican a una carrera académica que combina su práctica clínica con investigación original e innovadora. La beca puede renovarse por un segundo año. La Fundación está comprometida con el avance del campo mediante el desarrollo de la próxima generación de cirujanos-científicos vasculares líderes y prevé que esta beca permitirá al beneficiario realizar investigación vascular de gran impacto al inicio de su carrera, lo que le ayudará a optar a financiación independiente de agencias nacionales de salud y otras becas estatales y de fundaciones. El becario Wylie 2025 tendrá la oportunidad de trabajar con un antiguo becario Wylie, quien actuará como mentor/asesor y le brindará orientación en su proyecto de investigación.
Usos del premio
El premio podrá utilizarse para apoyar la investigación en las siguientes áreas:
Investigación básica, traslacional, clínica, centrada en el paciente, de resultados y servicios de salud, docencia, servicio comunitario y atención al paciente. Tenga en cuenta que la Fundación para el Avance de las Curas Vasculares no cubre los costos indirectos.
Elegibilidad
The Foundation intends to fund up to two pilot projects, not to exceed $75,000 and a project duration of up to 15 months. Awards may be made in categories 2(a) and/or 2(b).
2(a) Frederick M. Binkley Research Award
The Frederick M. Binkley Research Award honors the legacy of Dr. Frederick M. “Ted” Binkley, a pioneer in vascular surgery whose career was defined by excellence in science and patient care, and a commitment to collaboration.
The Award supports collaborative, patient-informed pilot research projects that address critical gaps in vascular health and have the potential to advance vascular science and improve patient outcomes. The goal is to fund projects at early stages of development and to encourage innovative approaches, readying these for larger scale clinical trials and/or other research studies.
Examples include:
● Mechanisms by which GLP-1 receptor agonists improve vascular outcomes.
● Biomarkers of wound healing.
● Microvascular function assessment.
● Inflammatory biomarkers as surrogate measures.
● Precision medicine approaches for PAD and CLTI.
● Clinical phenotyping, including calcific versus lipid-rich disease.
● Hormonal replacement therapy and vascular disease.
● Clinical decision support tools incorporating biomarker data.
● Leveraging existing databases and clinical datasets to generate novel mechanistic insights.
2(b) Collaborative Patient-Centered Research Award
The Collaborative Patient-Centered Research Award supports innovative pilot projects
designed to improve patient engagement, trust, education, implementation of
evidence-based therapies, health literacy, adherence, community engagement, and
participation in research.
Projects submitted under this award mechanism must demonstrate a clear connection to
the metabolic-vascular relationship and address how enhanced patient engagement,
education, or trust may improve outcomes among patients with PAD, CLTI, or other
vascular conditions influenced by metabolic dysfunction.
Examples include:
● Measuring and building trust in healthcare and science.
● Educational interventions that improve disease awareness and health literacy.
● Best practices for educational programs supporting clinical care or research
participation.
● Development of patient-facing educational tools and instructional videos.
● Leveraging nurse educators, pharmacists, patients, caregivers, and community
health workers.
● Addressing misinformation and improving adherence to medical therapy.
● Community-based approaches that improve cultural competency and
engagement.
● Strategies to improve participation in clinical trials and research programs.
Applicants should indicate which award mechanism for which they are applying.
Usos del premio
El premio podrá utilizarse para apoyar la investigación en las siguientes áreas:
Investigación básica, traslacional, clínica, centrada en el paciente, de resultados y servicios de salud, docencia, servicio comunitario y atención al paciente. Tenga en cuenta que la Fundación para el Avance de las Curas Vasculares no cubre los costos indirectos.
Elegibilidad
Proposals may not exceed five pages, single spaced, 11-point font, excluding supplemental appendices (maximum four pages).
Applications should include:
1. Key unmet need addressed by the proposal
2. Project goals and specific aims
3. Innovation
4. Milestones and deliverables
5. Research strategy and methods
6. Shared resources and how they will be used or developed
7. Impact of project results and future directions
8. Investigator Documentation:
● NIH/AHRQ Biographical Sketch Common Form or NIH Biographical Sketch Supplement (Current and Pending (Other) Support Common Form)
● Description of investigator roles and contributions
9. Budget and budget worksheet, including budgets by milestone and collaborator
Applicants are responsible for ensuring that all investigator documentation conforms to
NIH Common Forms requirements in effect at the time of submission.
Usos del premio
El premio podrá utilizarse para apoyar la investigación en las siguientes áreas:
Investigación básica, traslacional, clínica, centrada en el paciente, de resultados y servicios de salud, docencia, servicio comunitario y atención al paciente. Tenga en cuenta que la Fundación para el Avance de las Curas Vasculares no cubre los costos indirectos.
Elegibilidad
All researchers are invited to apply.
Proposals that do not include collaboration between two or more institutions will not be considered. Priority will be given to proposals led or co-led by attendees of the 2026 Vascular Health Innovation Summit (held on May 18, 2026 in San Francisco) when applications receive similar review scores.